BriaCell Therapeutics Corp. Warrant

BriaCell Therapeutics Corp. Warrant

BCTXZ - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$648.91K
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
BriaCell Therapeutics Corp. WarrantBriaCell Therapeutics Corp. Warrant-0.4--223%--
$1.97

Current Fair Value

1417.7% upside

Undervalued by 1417.7% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$648,912.00
Enterprise Value$-9,203,523.00
Earnings per Share$-6.97
Beta1.54
Outstanding Shares5,010,907

Return

Return on Equity-223.11%ROE
Return on Assets-147.22%
Return on Invested Capital-195.76%

Valuation & Multiples

P/E Ratio-0.37P/E Ratio
PEG-0.74PEG
Price to Sales-Price to Sales
Price to Book Ratio0.04Price to Book Ratio
Enterprise Value to Revenue-
Enterprise Value to EBIT-0.55
Enterprise Value to Net Income0
Total Debt to Enterprise0
Debt to Equity0Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About BriaCell Therapeutics Corp

17 employees
CEO: William V. Williams

BriaCell is an immuno-oncology focused biotechnology company developing targeted and effective approaches for the management of cancer.

Questions & Answers